高级别胶质瘤患者的补充疗法使用情况与生活质量
Complementary therapy use and quality of life in persons with high-grade gliomas.
作者信息
Fox Sherry, Laws Edward R, Anderson Frederick, Farace Elana
机构信息
University of Virginia School of Nursing, Charlottesville, USA.
出版信息
J Neurosci Nurs. 2006 Aug;38(4):212-20. doi: 10.1097/01376517-200608000-00003.
Studies have indicated that 30%-80% of cancer patients use complementary and alternative practices and products (CAPPs), but little is known about CAPPs use by persons with brain tumors. This secondary analysis of Glioma Outcomes Project data compared CAPPs users with nonusers, compared those who stopped using CAPPs with those who continued use, described frequency and patterns of CAPPs use, and compared the relationship of CAPPs use to self-reported quality of life (QOL) over time, in 186 persons with high-grade gliomas. CAPPs users at all three measurement points rated QOL higher, although not significantly higher, than nonusers. Study findings support further exploration of CAPPs use and its effects on key outcomes in persons with high-grade gliomas.
研究表明，30%-80%的癌症患者使用补充和替代疗法及产品（CAPPs），但对于脑肿瘤患者使用CAPPs的情况却知之甚少。这项对胶质瘤结局项目数据的二次分析，在186例高级别胶质瘤患者中，比较了CAPPs使用者与非使用者，比较了停止使用CAPPs者与继续使用者，描述了CAPPs的使用频率和模式，并比较了随着时间推移CAPPs使用与自我报告的生活质量（QOL）之间的关系。在所有三个测量点，CAPPs使用者对生活质量的评分均高于非使用者，尽管差异不显著。研究结果支持进一步探索高级别胶质瘤患者使用CAPPs的情况及其对关键结局的影响。
Zotero 插件